Sorrento Therapeutics Inc
OTC:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
OTC:SRNE
Watchlist
Price: 0.0032 USD 18.52% Market Closed
Market Cap: 1.8m USD

Wall Street
Price Targets

SRNE Price Targets Summary
Sorrento Therapeutics Inc

There are no price targets for SRNE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sorrento Therapeutics Inc Competitors:
Price Targets
CVAC
CureVac NV
11% Upside
CSL
CSL Ltd
41% Upside
VYGR
Voyager Therapeutics Inc
281% Upside
1530
3SBio Inc
54% Upside
PYXS
Pyxis Oncology Inc
509% Upside
COYA
Coya Therapeutics Inc
200% Upside
ALT
Altimmune Inc
387% Upside
SPRB
Spruce Biosciences Inc
149% Upside

Revenue
Forecast

Revenue Estimate
Sorrento Therapeutics Inc

For the last 11 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 55%. The projected CAGR for the next 3 years is 88%.

55%
Past Growth
88%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRNE's stock price target?
Not Available

SRNE doesn't have any price targets made by Wall Street professionals.

What is Sorrento Therapeutics Inc's Revenue forecast?
Projected CAGR
88%

For the last 11 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 55%. The projected CAGR for the next 3 years is 88%.

Back to Top